Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE:002223)
China
· Delayed Price · Currency is CNY 34.31
-0.12 (-0.35%)
Apr 29, 2025, 2:45 PM CST
SHE:002223 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 7,728 | 7,523 | 7,919 | 7,034 | 6,831 | 6,666 | Upgrade
|
| Other Revenue | 42.9 | 42.9 | 52.81 | 67.77 | 63.18 | 59.94 | Upgrade
|
| Revenue | 7,770 | 7,566 | 7,972 | 7,102 | 6,894 | 6,726 | Upgrade
|
| Revenue Growth (YoY) | 3.60% | -5.09% | 12.25% | 3.01% | 2.51% | 45.08% | Upgrade
|
| Cost of Revenue | 3,889 | 3,796 | 3,916 | 3,709 | 3,586 | 3,189 | Upgrade
|
| Gross Profit | 3,881 | 3,770 | 4,055 | 3,393 | 3,308 | 3,537 | Upgrade
|
| Selling, General & Admin | 1,883 | 1,790 | 1,499 | 1,452 | 1,334 | 1,114 | Upgrade
|
| Research & Development | 578.56 | 546.68 | 504.37 | 496.4 | 425.67 | 401.52 | Upgrade
|
| Other Operating Expenses | 13.53 | -3.3 | 32.96 | 44.67 | 31.99 | 27.28 | Upgrade
|
| Operating Expenses | 2,494 | 2,354 | 2,027 | 2,006 | 1,818 | 1,528 | Upgrade
|
| Operating Income | 1,387 | 1,416 | 2,029 | 1,387 | 1,490 | 2,009 | Upgrade
|
| Interest Expense | -14.32 | -20.73 | -58.55 | -57.74 | -30.49 | -15.25 | Upgrade
|
| Interest & Investment Income | 249.77 | 261.13 | 357.97 | 185.19 | 156.79 | 153.1 | Upgrade
|
| Currency Exchange Gain (Loss) | 19.69 | 19.69 | 3.66 | 99.33 | -0.04 | -138.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -8.57 | -0.94 | -2.41 | -1.4 | -1.79 | -0.59 | Upgrade
|
| EBT Excluding Unusual Items | 1,634 | 1,675 | 2,329 | 1,612 | 1,614 | 2,008 | Upgrade
|
| Impairment of Goodwill | -22.39 | -22.39 | -40.95 | -77.43 | - | -29.66 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.8 | - | -4.11 | 2.16 | 2.17 | -0.32 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.08 | 6.16 | 555.26 | 170.7 | 0.29 | -5.88 | Upgrade
|
| Asset Writedown | -2.12 | -2.09 | -13.76 | -1.99 | -0.86 | -0.12 | Upgrade
|
| Other Unusual Items | 275.7 | 275.7 | 23.13 | 136.63 | 85.75 | 46.72 | Upgrade
|
| Pretax Income | 1,892 | 1,933 | 2,849 | 1,842 | 1,702 | 2,019 | Upgrade
|
| Income Tax Expense | 125.31 | 128.56 | 472.36 | 269.73 | 217.82 | 262.04 | Upgrade
|
| Earnings From Continuing Operations | 1,766 | 1,804 | 2,376 | 1,573 | 1,484 | 1,757 | Upgrade
|
| Minority Interest in Earnings | 4.62 | 1.43 | 19.38 | 22.35 | -1.6 | 2.45 | Upgrade
|
| Net Income | 1,771 | 1,806 | 2,396 | 1,595 | 1,482 | 1,759 | Upgrade
|
| Net Income to Common | 1,771 | 1,806 | 2,396 | 1,595 | 1,482 | 1,759 | Upgrade
|
| Net Income Growth | -24.37% | -24.63% | 50.21% | 7.60% | -15.73% | 133.74% | Upgrade
|
| Shares Outstanding (Basic) | 998 | 998 | 994 | 991 | 995 | 1,005 | Upgrade
|
| Shares Outstanding (Diluted) | 998 | 998 | 994 | 991 | 995 | 1,005 | Upgrade
|
| Shares Change (YoY) | 0.27% | 0.35% | 0.35% | -0.42% | -1.02% | 0.18% | Upgrade
|
| EPS (Basic) | 1.78 | 1.81 | 2.41 | 1.61 | 1.49 | 1.75 | Upgrade
|
| EPS (Diluted) | 1.78 | 1.81 | 2.41 | 1.61 | 1.49 | 1.75 | Upgrade
|
| EPS Growth | -24.57% | -24.90% | 49.69% | 8.05% | -14.86% | 133.33% | Upgrade
|
| Free Cash Flow | 1,661 | 1,688 | 1,994 | 1,926 | 916.88 | 2,152 | Upgrade
|
| Free Cash Flow Per Share | 1.67 | 1.69 | 2.01 | 1.94 | 0.92 | 2.14 | Upgrade
|
| Dividend Per Share | 0.800 | 0.800 | 0.800 | 0.600 | 0.300 | 0.300 | Upgrade
|
| Dividend Growth | - | - | 33.33% | 100.00% | - | -25.00% | Upgrade
|
| Gross Margin | 49.95% | 49.83% | 50.87% | 47.77% | 47.99% | 52.59% | Upgrade
|
| Operating Margin | 17.85% | 18.72% | 25.45% | 19.53% | 21.61% | 29.87% | Upgrade
|
| Profit Margin | 22.79% | 23.87% | 30.05% | 22.46% | 21.50% | 26.15% | Upgrade
|
| Free Cash Flow Margin | 21.37% | 22.31% | 25.02% | 27.11% | 13.30% | 32.00% | Upgrade
|
| EBITDA | 1,599 | 1,627 | 2,236 | 1,586 | 1,677 | 2,170 | Upgrade
|
| EBITDA Margin | 20.57% | 21.50% | 28.04% | 22.33% | 24.33% | 32.26% | Upgrade
|
| D&A For EBITDA | 211.54 | 210.62 | 206.92 | 199.14 | 187.27 | 161.02 | Upgrade
|
| EBIT | 1,387 | 1,416 | 2,029 | 1,387 | 1,490 | 2,009 | Upgrade
|
| EBIT Margin | 17.85% | 18.72% | 25.45% | 19.53% | 21.61% | 29.87% | Upgrade
|
| Effective Tax Rate | 6.62% | 6.65% | 16.58% | 14.64% | 12.80% | 12.98% | Upgrade
|
| Revenue as Reported | 7,770 | 7,566 | 7,972 | 7,102 | 6,894 | 6,726 | Upgrade
|
| Advertising Expenses | - | 171.34 | 121.54 | 147.18 | - | - | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.